Blogs about: Targacept
Featured Blog
Targacept trades rights with AstraZeneca
Targacept has announced that it has altered its licensing agreement with AstraZeneca. Under the terms of the agreement, AstraZeneca has been given the right to develop and commercialize Targacept’s AZ… more →
Silico Research
Targacept trades rights with AstraZeneca
wrote 2 months ago: Targacept has announced that it has altered its licensing agreement with AstraZeneca. Under the term … more →
How MIT is going to kill scientific innovation in America
— 37 comments
wrote 7 months ago: This is a quick one. I found the blog Noahpinion as I was following a link from a silly article in T … more →
CFO Moves – week ending June 8, 2012
wrote 11 months ago: CFO Moves this week include: Sara Lee Corp. Apex Clearing Corporation Dunkin’ Brands Group Eng … more →
Targacept
wrote 11 months ago: In the May issue of NeuroPerspective, there was a sidebar entitled ‘Triage Time at Targacept, … more →
Targacept lays off 46% of workforce
wrote 1 year ago: Targacept has announced that it reduce it’s workforce by 65 employees, or approximately 46% of … more →
Targacept to layoff 46 percent of workforce
— 1 comment
wrote 1 year ago: Targacept is slashing its workforce by nearly half, part of a restructuring plan that comes one mont … more →
Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)
wrote 1 year ago: Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow … more →
AstraZeneca and Targacept discontinue development of TC-5214 for depression
wrote 1 year ago: AstraZeneca and Targacept have announced top-line results from the remaining Phase 3 studies investi … more →
AstraZeneca progresses the development of Targacept’s Alzheimer’s candidate
wrote 1 year ago: Targacept has announced that AstraZeneca has informed the company that it plans to progress the deve … more →
TC-5214 shows no benefits in Phase III trials
wrote 1 year ago: TC-5214 an antidepressant that works by calming nicotine receptors in the brain and developed by Tar … more →
Targacept regains full rights to TC-5619
wrote 2 years ago: Targacept has announced that AstraZeneca will not exercise its option to license a potential schizop … more →
Targacept's TC-5619 fails to meet clinical goals in Phase 2 trial
wrote 2 years ago: Targacept has announced that Phase 2 proof of concept trial of TC-5619 as a treatment for adults wit … more →
GlaxoSmithKline terminates Targacept alliance
wrote 2 years ago: GlaxoSmithKline has terminated a strategic alliance agreement with Targacept. According to Targacept … more →
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214
wrote 2 years ago: AstraZeneca and Targacept have announced the enrolment of the first patient in the Phase IIb clinica … more →
Targacept's AZD1466 disappoints in Phase 2 study
wrote 2 years ago: Targacept has announced top-line results from a Phase 2 clinical trial of AZD1446 conducted by Astra … more →
Targacept and AstraZeneca launch Phase 3 study of TC-5214
wrote 2 years ago: Targacept and AstraZeneca have announced that they have launched a Phase 3 study of TC-5214. AstraZe … more →
GSK pain rationalisation hits XenoPort and Targacept
wrote 3 years ago: GlaxoSmithKline has announced that its neuroscience researchers will focus on inflammatory and degen … more →
AstraZeneca and Targacept in alliance to treat depression
wrote 3 years ago: AstraZeneca and Targacept signed a collaboration and license agreement on December 3 2009 for the gl … more →
Targacept receive $10 million milestone payment from AstraZeneca
wrote 3 years ago: Targacept has announced that AstraZeneca has informed Targacept that it plans to conduct further dev … more →
